Skip to main content
SpringerLink
Log in

The EMEA and the US FDA have created a common application for orphan designation of medicines in the EU and the US.

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMEA.The European Union and the FDA working together to create Common Application for Orphan Designation for Medicines. Media Release: 26 Nov 2007. Available from: URL: http://emea.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The EMEA and the US FDA have created a common application for orphan designation of medicines in the EU and the US.. Pharmacoecon. Outcomes News 543, 11 (2007). https://doi.org/10.2165/00151234-200705430-00032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705430-00032

Keywords

Search

Navigation